Business Update: Mega drug deal
Mar. 9 - Wall Street is taking heart from Merck's plans to wed Schering-Plough in a $41 billion deal.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?d=yIl2AUoC8zA" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=8rLWik_pFMc:tUojPGY1qVc:yIl2AUoC8zA) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=8rLWik_pFMc:tUojPGY1qVc:V_sGLiPBpWU" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=8rLWik_pFMc:tUojPGY1qVc:V_sGLiPBpWU) <img src="http://feeds2.feedburner.com/~ff/reuters/USVideoBusiness?i=8rLWik_pFMc:tUojPGY1qVc:F7zBnMyn0Lo" border="0"></img> (http://feeds.reuters.com/~ff/reuters/USVideoBusiness?a=8rLWik_pFMc:tUojPGY1qVc:F7zBnMyn0Lo)
</div><img src="http://feeds2.feedburner.com/~r/reuters/USVideoBusiness/~4/8rLWik_pFMc" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/USVideoBusiness/~3/8rLWik_pFMc/video